Bruce Mackle | Managing Director, LifeSci Advisors |
Steven Fruchtman | President and Chief Executive Officer |
Michael Saunders | Interim Chief Medical Officer |
Mark Guerin | Chief Operating Officer and Chief Financial Officer |
Joseph Pantginis | H.C. Wainwright |
Ahu Demir | Ladenburg Thalmann |
Robert LeBoyer | Noble Life Science Partners |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in listen-only mode.
Following management's prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today, May 15, 2023.